AJMC April 2, 2025
Key Takeaways
- Biosimilar adoption and market dynamics are reshaping managed care, with the Inflation Reduction Act impacting innovation and market incentives.
- Specialty pharmaceuticals, particularly GLP-1 drugs, are driving market growth, influencing diabetes care and prescription patterns.
- Pharmacy closures have created “pharmacy deserts,” affecting medication access in disadvantaged communities, highlighting health inequities.
- The growing role of pharmacists in vaccine administration and patient education reflects broader trends in pharmacy-based healthcare delivery.
Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in managed care, creating both challenges and opportunities for stakeholders, as explored by speakers at the Academy of Managed Care Pharmacy’s annual meeting.
Rising biosimilar adoption, shifting pharmaceutical market dynamics, and mounting supply chain vulnerabilities...
Today's Sponsors
Today's Sponsor